Cell and Gene Therapy
Oxford Biomedica opportunity for UCL supervisors to apply for a fully-funded doctoral studentship.
|
|
|
The BBSRC Advanced Bioscience of Viral Products Collaborative Training Partnership (ABViP CTP) are providing an opportunity for UCL supervisors to apply for a fully-funded doctoral studentship to begin in Sep 2022.
The CTP is a collaboration with Oxford Biomedica, UCL and University of Oxford and will train a cohort of 24 students over a three year period to address the acute viral vector skills shortage for future gene therapy and vaccines. The CTP will therefore fund 4 doctoral students per year at UCL (12 in total).
|
|
|
To register your interest, please contact Dr Qasim Rafiq, UCL Biochemical Engineering (q.rafiq@ucl.ac.uk), who will be able to provide Project Proposal Form and Guidance Notes.
The Department of Biochemical Engineering led the UCL input into the CTP proposal and will be responsible for monitoring student recruitment and progress and reporting on ED&I metrics. Each studentship must therefore have a Supervisor or Secondary Supervisor from the department.
The call for project proposals will close on Monday 6th December.
|
|
Repurposing
Catch up on the recent Repurposing TIN seminar series
|
|
Over the past few months, the Repurposing TIN has hosted a number of events featuring multidisciplinary speakers, to address some of the common challenges in the Drug Repurposing space.
The recordings for this series are now available to all. Please watch the seminars if you are a basic and/or translational researcher at any career stage or are from industry and involved in the Drug Repurposing space.
|
|
|
Repurposing TIN Seminar 1: Computational Technology & AI in Drug Repurposing
Speaker affiliations: UCL, Medicines Discovery Catapult, Healx, Biovista
Recording link: https://mediacentral.ucl.ac.uk/Play/67845
Repurposing TIN Seminar 2: Addressing Hurdles from the Research Community
Speaker affiliations: UCL, Healx, Cures Within Reach
Recording link: https://mediacentral.ucl.ac.uk/Play/70622
Repurposing TIN Seminar 3: How Partnership Drives Innovation
Speaker affiliations: UCL, AstraZeneca, Findacure, AMO-Pharma, Anticancer Fund, Consorzio per Valutazioni Biologiche e Farmacologiche, AKU Society, Biovista
Recording link: https://mediacentral.ucl.ac.uk/Play/71186
Repurposing TIN Seminar 4: Innovative approaches to accelerate drug repurposing
Speaker affiliations: UCL, Oncoheroes Biosciences, Numedicus, St George Street Capital, British Generic Manufacturers association, Reboot Rx, DATA-CAN
Recording link: https://mediacentral.ucl.ac.uk/Play/76901
If you have any questions about Repurposing opportunities at UCL, please join the Repurposing TIN Teams community, and feel free to email TIN Coordinator Dr Asha Recino (a.recino@ucl.ac.uk) to discuss partnership opportunities.
|
|
Small Molecules
PROTAC & AUTAC Opportunity for UCL researchers
|
|
|
PROTACs/AUTACs are a new technology that chemically knocks-out a protein of interest by directing it to the Proteasome or to Autophagy. They are particularly useful for cell biology and in-vivo studies.
The Small Molecules TIN has purchased a stock of molecules suitable for modification into functional PROTACs. We have also purchased a stock of AUTAC4 (HY-W073762-Autophagy Ligand and HY-128837-Nutlin carboxylic acid, a mitophagy enhancer) that does not require further chemistry. These molecules are being made freely available to interested research groups across UCL.
|
|
|
|
If you would like to take advantage of this opportunity to obtain a PROTAC or AUTAC for your research, please complete an expression of interest form below (we encourage you to do so at your earliest convenience, as there is limited stock available for these molecules).
|
|
ACCELERATE Team Challenge – Update
The second round of the Team Challenge is well underway - four interdisciplinary teams comprising diverse researchers from across UCL and the three UCL Biomedical Research Centres are putting the final touches on their proposals and pitches in preparation for the panel session next week, where they will pitch their healthcare innovation ideas for funding. All the best to the teams with their pitches!
The ACCELERATE Team Challenge is a seven-week training initiative that aims to promote and support interdisciplinary team work for healthcare innovation through training, hands-on experience, and the opportunity for funding.
|
|
|
|
|
